During the past decade, INSERM conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "INSERM" #1 collaborator was "Erasmus Medical Center" with 1 trials as a collaborator, "European Union" with 1 trials as a collaborator, "Federal University of Bahia" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "Instituto Mexicano del Seguro Social" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "INSERM" are "Zika Virus" (2 trials) and "Pregnancy Related" (1 trials). Many other conditions were trialed in "INSERM" in a lesser frequency.

The vast majority of trials in "INSERM" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "INSERM". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in INSERM, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in INSERM, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".